Pretreatment of BC cells with the lysosomal enzyme inhibitor bafilomycin A completely abrogated the sorafenib-induced Akt degradation, demonstrating that sorafenib acts at a post-transcriptional level by inducing lysosome-dependent degradation of the Akt protein [47].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}